Literature DB >> 26552366

Protein C-terminal enzymatic labeling identifies novel caspase cleavages during the apoptosis of multiple myeloma cells induced by kinase inhibition.

Wenwen Duan1, Suping Chen1, Yang Zhang1, Dan Li1, Rong Wang1, Shi Chen1, Junbei Li1, Xiaoyan Qiu1, Guoqiang Xu1.   

Abstract

Caspase activation and proteolytic cleavages are the major events in the early stage of apoptosis. Identification of protein substrates cleaved by caspases will reveal the occurrence of the early events in the apoptotic process and may provide potential drug targets for cancer therapy. Although several N-terminal MS-based proteomic approaches have been developed to identify proteolytic cleavages, these methods have their inherent drawbacks. Here we apply a previously developed proteomic approach, protein C-terminal enzymatic labeling (ProC-TEL), to identify caspase cleavage events occurring in the early stage of the apoptosis of a myeloma cell line induced by kinase inhibition. Both previously identified and novel caspase cleavage sites are detected and the reduction of the expression level of several proteins is confirmed biochemically upon kinase inhibition although the current ProC-TEL procedure is not fully optimized to provide peptide identifications comparable to N-terminal labeling approaches. The identified cleaved proteins form a complex interaction network with central hubs determining morphological changes during the apoptosis. Sequence analyses show that some ProC-TEL identified caspase cleavage events are unidentifiable when traditional N-terminomic approaches are utilized. This work demonstrates that ProC-TEL is a complementary approach to the N-terminomics for the identification of proteolytic cleavage events such as caspase cleavages in signaling pathways.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Apoptosis; Caspase cleavage; Cell biology; Kinase inhibitor; Multiple myeloma; Protein C-terminal enzymatic labeling

Mesh:

Substances:

Year:  2015        PMID: 26552366     DOI: 10.1002/pmic.201500356

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  5 in total

1.  Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.

Authors:  Suping Chen; Jing Yang; Yang Zhang; Chunyan Duan; Qing Liu; Zhengyun Huang; Ying Xu; Liang Zhou; Guoqiang Xu
Journal:  J Biol Chem       Date:  2018-06-05       Impact factor: 5.157

2.  The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.

Authors:  Xun Liu; Yang Zhang; Zhanhong Hu; Qian Li; Lu Yang; Guoqiang Xu
Journal:  Protein J       Date:  2018-04       Impact factor: 2.371

3.  Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.

Authors:  Qihui Lian; Yuan Gao; Qian Li; Xian He; Xiaogang Jiang; Zhongjian Pu; Guoqiang Xu
Journal:  Protein J       Date:  2020-10-03       Impact factor: 2.371

4.  Centrosomal protein Dzip1l binds Cby, promotes ciliary bud formation, and acts redundantly with Bromi to regulate ciliogenesis in the mouse.

Authors:  Chengbing Wang; Jia Li; Ken-Ichi Takemaru; Xiaogang Jiang; Guoqiang Xu; Baolin Wang
Journal:  Development       Date:  2018-03-15       Impact factor: 6.868

Review 5.  Multiple myeloma in the marrow: pathogenesis and treatments.

Authors:  Heather Fairfield; Carolyne Falank; Lindsey Avery; Michaela R Reagan
Journal:  Ann N Y Acad Sci       Date:  2016-01       Impact factor: 5.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.